APA (7th ed.) Citation

Sequist, L. V., Fidias, P. M., Temel, J. S., Kolevska, T., Rabin, M. S., Boccia, R. V., . . . Lynch, T. J. (2009). Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer. Journal of thoracic oncology, 4(11), 1389-1396. https://doi.org/10.1097/JTO.0b013e3181b6b84b

Chicago Style (17th ed.) Citation

Sequist, Lecia V., et al. "Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer." Journal of Thoracic Oncology 4, no. 11 (2009): 1389-1396. https://doi.org/10.1097/JTO.0b013e3181b6b84b.

MLA (9th ed.) Citation

Sequist, Lecia V., et al. "Phase 1-2a Multicenter Dose-Ranging Study of Canfosfamide in Combination with Carboplatin and Paclitaxel as First-Line Therapy for Patients with Advanced Non-small Cell Lung Cancer." Journal of Thoracic Oncology, vol. 4, no. 11, 2009, pp. 1389-1396, https://doi.org/10.1097/JTO.0b013e3181b6b84b.